Cargando…

Rapalink-1 Targets Glioblastoma Stem Cells and Acts Synergistically with Tumor Treating Fields to Reduce Resistance against Temozolomide

SIMPLE SUMMARY: Glioblastoma (GBM) resistance to standard treatment is driven by stem-like cell behavior and epithelial-like-mesenchymal transition. The main purpose of this paper was to functionally validate a novel discovered pharmacological strategy to treat GBM, the dual mTOR pathway inhibitor R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vargas-Toscano, Andres, Nickel, Ann-Christin, Li, Guanzhang, Kamp, Marcel Alexander, Muhammad, Sajjad, Leprivier, Gabriel, Fritsche, Ellen, Barker, Roger A., Sabel, Michael, Steiger, Hans-Jakob, Zhang, Wei, Hänggi, Daniel, Kahlert, Ulf Dietrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766508/ https://www.ncbi.nlm.nih.gov/pubmed/33371210 http://dx.doi.org/10.3390/cancers12123859

Ejemplares similares

Robot technology identifies a Parkinsonian therapeutics repurpose to target stem cells of glioblastoma
por: Vargas-Toscano, Andres, et al.
Publicado: (2020)

Carbonic Anhydrase XII is a Clinically Significant, Molecular Tumor-Subtype Specific Therapeutic Target in Glioma with the Potential to Combat Invasion of Brain Tumor Cells
por: Li, Guanzhang, et al.
Publicado: (2021)

Different Calculation Strategies Are Congruent in Determining Chemotherapy Resistance of Brain Tumors In Vitro
por: Fischer, Igor, et al.
Publicado: (2020)

An inexpensive and easy-to-implement approach to a Quality Management System for an academic research lab
por: Hewera, Michael, et al.
Publicado: (2020)

A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma
por: Herrera-Rios, Dayana, et al.
Publicado: (2020)

Age-stratified clinical performance and survival of patients with IDH-wildtype glioblastoma homogeneously treated by radiotherapy with concomitant and maintenance temozolomide
por: Berger, Kerstin, et al.
Publicado: (2020)

A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity
por: Koch, Katharina, et al.
Publicado: (2020)

A Preclinical Pipeline for Translational Precision Medicine—Experiences from a Transdisciplinary Brain Tumor Stem Cell Project
por: Vargas-Toscano, Andres, et al.
Publicado: (2021)

Testing the Stability of Drug Resistance on Cryopreserved, Gene-Engineered Human Induced Pluripotent Stem Cells
por: Khan, Dilaware, et al.
Publicado: (2021)

mTOR Inhibitor Rapalink-1 Prevents Ethanol-Induced Senescence in Endothelial Cells
por: Zhou, Huakang, et al.
Publicado: (2023)

Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs)
por: Koch, Katharina, et al.
Publicado: (2021)

Augmented Therapeutic Potential of Glutaminase Inhibitor CB839 in Glioblastoma Stem Cells Using Gold Nanoparticle Delivery
por: Giesen, Beatriz, et al.
Publicado: (2021)

Effects of Dendrimer-microRNA Nanoformulations against Glioblastoma Stem Cells
por: Knauer, Nadezhda, et al.
Publicado: (2023)

The Synergistic Effect of Combination Progesterone and Temozolomide on Human Glioblastoma Cells
por: Atif, Fahim, et al.
Publicado: (2015)

Siderol Inhibits Proliferation of Glioblastoma Cells and Acts Synergistically with Temozolomide
por: Giannakopoulou, Maria, et al.
Publicado: (2022)

Brain Immune Interactions—Novel Emerging Options to Treat Acute Ischemic Brain Injury
por: Muhammad, Sajjad, et al.
Publicado: (2021)

The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells
por: Mazor, Gal, et al.
Publicado: (2019)

Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro
por: Suwala, Abigail Kora, et al.
Publicado: (2018)

WNT/β-Catenin-Mediated Resistance to Glucose Deprivation in Glioblastoma Stem-like Cells
por: Yusuf, Suad, et al.
Publicado: (2022)

Current biomarker-associated procedures of cancer modeling-a reference in the context of IDH1 mutant glioma
por: Mehrjardi, Narges Zare, et al.
Publicado: (2020)

Synergistic Effects of Crizotinib and Temozolomide in Experimental FIG-ROS1 Fusion-Positive Glioblastoma
por: Das, Arabinda, et al.
Publicado: (2015)

Autophagy enhancement contributes to the synergistic effect of vitamin D in temozolomide-based glioblastoma chemotherapy
por: BAK, DONG-HO, et al.
Publicado: (2016)

Synergistic Effects of Resveratrol and Temozolomide Against Glioblastoma Cells: Underlying Mechanism and Therapeutic Implications
por: Liu, Yusi, et al.
Publicado: (2020)

Targeting High Mobility Group Box 1 in Subarachnoid Hemorrhage: A Systematic Review
por: Muhammad, Sajjad, et al.
Publicado: (2020)

eLabFTW as an Open Science tool to improve the quality and translation of preclinical research
por: Hewera, Michael, et al.
Publicado: (2021)

Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia–Reperfusion With Increased Blood–Brain Barrier Disruption
por: Chi, Oak Z., et al.
Publicado: (2021)

Elevated Systemic IL-10 Levels Indicate Immunodepression Leading to Nosocomial Infections after Aneurysmal Subarachnoid Hemorrhage (SAH) in Patients
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2020)

Role of Adaptor Protein Myeloid Differentiation 88 (MyD88) in Post-Subarachnoid Hemorrhage Inflammation: A Systematic Review
por: Ahmed, Hammad, et al.
Publicado: (2021)

Commentary: Rapalink-1 Increased Infarct Size in Early Cerebral Ischemia–Reperfusion With Increased Blood–Brain Barrier Disruption
por: Beard, Daniel J., et al.
Publicado: (2021)

Correlation of psychooncological distress- screening and quality of life assessment in neurosurgical patients
por: Hoffmann, Kira, et al.
Publicado: (2017)

Calcium and Potassium Channels in Experimental Subarachnoid Hemorrhage and Transient Global Ischemia
por: Kamp, Marcel A., et al.
Publicado: (2012)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Differential polarization and activation dynamics of systemic T helper cell subsets after aneurysmal subarachnoid hemorrhage (SAH) and during post-SAH complications
por: Chaudhry, Shafqat Rasul, et al.
Publicado: (2021)

Temozolomide and tranilast synergistic antiproliferative effect on human glioblastoma multiforme cell line (U87MG)
por: Khazaei, Mozafar, et al.
Publicado: (2019)

Mitochondrial dysfunction contributes to Rapamycin-induced apoptosis of Human Glioblastoma Cells - A synergistic effect with Temozolomide
por: Zimmerman, Mary A, et al.
Publicado: (2020)

Dual-mTOR Inhibitor Rapalink-1 Reduces Prostate Cancer Patient-Derived Xenograft Growth and Alters Tumor Heterogeneity
por: La Manna, Federico, et al.
Publicado: (2020)

Accelerated hyperfractionation plus temozolomide in glioblastoma
por: Kaul, David, et al.
Publicado: (2016)

Strategies of temozolomide in future glioblastoma treatment
por: Lee, Chooi Yeng
Publicado: (2017)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
por: Saha, Dipongkor, et al.
Publicado: (2020)

Evaluation of a Murine Single-Blood-Injection SAH Model
por: Kamp, Marcel A., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_8m0i0rsm7abbuupgdq160qnh18